These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32288981)

  • 1. On the analysis of a multi-regions discrete SIR epidemic model: an optimal control approach.
    Zakary O; Rachik M; Elmouki I
    Int J Dyn Control; 2017; 5(3):917-930. PubMed ID: 32288981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-regions discrete-time epidemic model with a travel-blocking vicinity optimal control approach on patches.
    Zakary O; Rachik M; Elmouki I; Lazaiz S
    Adv Differ Equ; 2017; 2017(1):120. PubMed ID: 32226449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new epidemic modeling approach: Multi-regions discrete-time model with travel-blocking vicinity optimal control strategy.
    Zakary O; Rachik M; Elmouki I
    Infect Dis Model; 2017 Aug; 2(3):304-322. PubMed ID: 29928744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-optimal control strategies in SIR epidemic models.
    Bolzoni L; Bonacini E; Soresina C; Groppi M
    Math Biosci; 2017 Oct; 292():86-96. PubMed ID: 28801246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal control of epidemic size and duration with limited resources.
    Bolzoni L; Bonacini E; Della Marca R; Groppi M
    Math Biosci; 2019 Sep; 315():108232. PubMed ID: 31330135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal vaccination and treatment policies for regional approximate controllability of the time-fractional reaction-diffusion SIR epidemic systems.
    Ge F; Chen Y
    ISA Trans; 2021 Sep; 115():143-152. PubMed ID: 33487399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal control and cost-effectiveness analysis for the human melioidosis model.
    Engida HA; Gathungu DK; Ferede MM; Belay MA; Kawe PC; Mataru B
    Heliyon; 2024 Feb; 10(4):e26487. PubMed ID: 38434022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-region discrete time mathematical modeling of the dynamics of Covid-19 virus propagation using optimal control.
    Khajji B; Kada D; Balatif O; Rachik M
    J Appl Math Comput; 2020; 64(1-2):255-281. PubMed ID: 32390786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal control and cost-effectiveness analysis for leptospirosis epidemic.
    Engida HA; Theuri DM; Gathungu DK; Gachohi J
    J Biol Dyn; 2023 Dec; 17(1):2248178. PubMed ID: 37695860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Optimal Control of Infectious Diseases in a Model-Free Scenario.
    Nepomuceno EG; Peixoto MLC; Lacerda MJ; Campanharo ASLO; Takahashi RHC; Aguirre LA
    SN Comput Sci; 2021; 2(5):405. PubMed ID: 34396152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamical analysis and control strategies of an SIVS epidemic model with imperfect vaccination on scale-free networks.
    Lv W; Ke Q; Li K
    Nonlinear Dyn; 2020; 99(2):1507-1523. PubMed ID: 32214672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trade-Off between COVID-19 Pandemic Prevention and Control and Economic Stimulus.
    Liu F; Ma Z; Wang Z; Xie S
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bézier curve parametrisation and echo state network methods for solving optimal control problems of SIR model.
    Kmet T; Kmetova M
    Biosystems; 2019 Dec; 186():104029. PubMed ID: 31540680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the optimal control of SIR model with Erlang-distributed infectious period: isolation strategies.
    Bolzoni L; Della Marca R; Groppi M
    J Math Biol; 2021 Sep; 83(4):36. PubMed ID: 34550465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Control of a Delayed SIRS Epidemic Model with Vaccination and Treatment.
    Laarabi H; Abta A; Hattaf K
    Acta Biotheor; 2015 Jun; 63(2):87-97. PubMed ID: 25578405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal vaccine allocation for the control of sexually transmitted infections.
    Saldaña F; Steindorf V; Srivastav AK; Stollenwerk N; Aguiar M
    J Math Biol; 2023 Apr; 86(5):75. PubMed ID: 37058156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison.
    Sarv Ahrabi S; Momenzadeh A
    J Math Biol; 2020 Aug; 81(2):691-723. PubMed ID: 32712711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal treatment of an SIR epidemic model with time delay.
    Zaman G; Kang YH; Jung IH
    Biosystems; 2009 Oct; 98(1):43-50. PubMed ID: 19464340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.